We Just Learned Something New About Verve Therapeutics Inc (NASDAQ: VERV) This Week With Its -8.32% Loss
During the last session, Verve Therapeutics Inc (NASDAQ:VERV)’s traded shares were 1.35 million, with the beta value of the company hitting 1.77. At the end